Evidence map›Paper›PMID 39638274›Full record

ArticleAmerican heart journal2025

Health status outcomes after acute myocardial infarction in patients without standard modifiable risk factors.

Nobuhiro Ikemura, Paul S Chan, Kensey Gosch, Dan D Nguyen, Charles F Sherrod Iv, Mirza Khan, Yuan Lu, Mitsuaki Sawano, Harlan M Krumholz, John A Spertus

Abstract readMulticenter Study
In one paragraph

Article in American heart journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nobuhiro IkemuraUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO; Department of Cardiology, Keio University School of Medicine, Tokyo. Electronic address: ikemu0129@gmail.com.
Paul S ChanUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO.
Kensey GoschSaint Luke's Mid America Heart Institute, Kansas City, MO.
Dan D NguyenUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO.
Charles F Sherrod IvUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO.
Mirza KhanUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO.
Yuan LuCenter for Outcomes Research & Evaluation, Yale University School of Medicine, New Haven, CT.
Mitsuaki SawanoDepartment of Cardiology, Keio University School of Medicine, Tokyo; Center for Outcomes Research & Evaluation, Yale University School of Medicine, New Haven, CT.
Harlan M KrumholzCenter for Outcomes Research & Evaluation, Yale University School of Medicine, New Haven, CT.
John A SpertusUniversity of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
SCCOR in Cardiac Dysfunction and DiseaseP50HL077113 · NHLBI · WASHINGTON UNIVERSITY · PI KELLY, DANIEL PATRICK · 2005 to 2009
$13.4M
CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAMT32HL110837 · NHLBI · UNIVERSITY OF MISSOURI KANSAS CITY · PI JOHN A SPERTUS · 2012 to 2026
$5.0M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS P50 HL077113NHLBI NIH HHS T32 HL110837
6 · The paper itself

Abstract

backgroundPrior studies of patients presenting with acute myocardial infarction (AMI) without Standard Modifiable Risk Factors (SMuRFs), such as diabetes, dyslipidemia, hypertension, and smoking, reported higher in-hospital but lower long-term mortality than those with SMuRFs. However, the impact of SMuRFs on health status outcomes (patients' symptoms, function, and quality of life) after a first AMI are unknown.

methodsData from 2 prospective registries, PREMIER and TRIUMPH, were used to identify patients with no prior history of coronary disease hospitalized at 31 U.S. hospitals for AMI between 2003 and 2008. Serial health status over 12 months was collected using the Seattle Angina Questionnaire (SAQ) Summary Score. Changes in SAQ over 12 months were compared between patients with and without SMuRFs using hierarchical linear mixed models with sequential adjustments for baseline SAQ scores, clinical, and sociodemographic characteristics.

resultsAmong 4076 patients with a first AMI (mean age 58.4 ± 12.4, 34% female, 22% Black), 569 (14.0%) presented without SMuRFs. Compared with patients with SMuRFs, those without SMuRFs were more likely to be male, White, have higher income and education, fewer depressive symptoms, and higher baseline SAQ Summary Scores (83.5 ± 13.2 vs. 79.6 ± 16.5). After adjusting for baseline SAQ scores, patients without SMuRFs had larger SAQ Summary Score improvements at 12 months than those with SMuRFs (adjusted difference between groups = 2.61 points, 95% CI: 1.29-3.93), but sequential adjustment for clinical and socioeconomic characteristics attenuated this difference (1.69 points, 95% CI 0.40-1.97).

conclusionsAmong AMI patients, those without modifiable risk factors had similar health status at 12-months as compared with those having modifiable cardiovascular risk factors, which should provide reassurance to those with less targets for secondary prevention.

Indexed as

Health StatusMyocardial InfarctionQuality of LifeAgedFemaleHumansMaleMiddle AgedProspective StudiesRegistriesRisk FactorsUnited States

Identifiers

PMID39638274
PMCPMC11810589

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.